FDA Lacks Clear Strategy to Reduce Smoking, Outside Review Says

December 19, 2022, 10:11 PM UTC

The US Food and Drug Administration’s tobacco division lacks a clear strategy to regulate the industry and reduce smoking, according to an outside review requested by the agency’s commissioner.

The Center for Tobacco Products is reacting to problems instead of being ready to deal with them, said the report from the Reagan-Udall Foundation, a nonprofit helping with oversight of an agency that’s come under fire over its regulation of tobacco products such as flavored vapors popular among youth.

The agency needs to work better with the administration “to make enforcement of the tobacco laws a government-wide priority,” the report ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.